Roxas, Glore Jean V.

HRN: 12-96-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2025
CEFUROXIME 500MG (TAB)
03/16/2025
03/23/2025
PO
500mg
BID
Thinly MSAF; RMLE And Repair
Waiting Final Action 
03/17/2025
CEFUROXIME 1.5GM (VIAL)
03/17/2025
03/18/2025
IV
1.5
Q8hr X 3 Doses
Sp NSVD With RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: